1201986-72-2

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 144620-11-1 3-(4-fluorophenyl)pyrrolidine 
• 1263285-96-6 tert-butyl 3-(4-fluorophenyl)pyrrolidine-1-carboxylate 

Downstream Products

• 1048703-18-9 (R)-3-(4-fluoro-phenyl)-pyrrolidine 
• 1384268-53-4 (R)-3-(4-fluorophenyl)pyrrolidine hydrochloride 
• 1201986-55-1 ((R)-3-(4-fluorophenyl)pyrrolidin-1-yl)((2S,4R)-4-(fluorophenyl)pyrrolidin-2-yl)methanone hydrochloride 
• 1201987-30-5 (2S,4R)-tert-butyl 4-(4-fluorophenyl)-2-((R)-3-(4-fluorophenyl)pyrrolidine-1-carbonyl)pyrrolidine-1-carboxylate 

Relevant academic research and scientific papers

NOVEL COMPOUNDS FOR THE TREATMENT OF PARASITIC INFECTIONS

The present invention relates to novel compounds or pharmaceutically acceptable salts thereof, corresponding compositions, and methods and/or uses in therapy, for example in the treatment of parasitic infections such as malaria, in particular infection by

HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS

The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, solvates thereof, that bind to Inhibitor of Apoptosis Proteins (IAPs). The compounds of the invention may be used as diagnostic and therapeutic agents in the